Edison Oncology Holding Corp. (EOHC)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	74.79M
Revenue (ttm)	446,091 -21.7%
Net Income	-4.64M
EPS	-0.56
Shares Out	8.31M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About EOHC

Edison Oncology is a clinical-stage biopharmaceutical company focused on developing innovative small-molecule therapies for cancer by unlocking the potential of existing drugs and compounds. We seek to make meaningful improvements through strategic reformulation and / or repurposing using a modernized understanding of their mechanisms of action to address significant unmet medical needs. Our development strategy prioritizes product candidates that may qualify for accelerated marketing approval under the U.S. Food and Drug Administration’s exped...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2018
• Country: United States
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: EOHC
• Website: https://www.edisononcology.com/